ISO 27001 – information security standard for Modulight

Modulight achieved the international ISO 27001 information security standard certification today on February 28, 2024. The certification of the information security management system demonstrates the organization’s commitment to protecting information and managing high-level of information security. “We are expanding the use of cloud services in accordance with our SaaS business model and are making strong progress in transitioning to a pay-per-treatment (PPT) payment model. Managing patient information requires very high-level information security processes, which is why we started to pursue the ISO 27001 certification in Continue reading →Modulight achieved the international ISO 27001 information security standard certification today on February 28, 2024. The certification of the information security management system demonstrates the organization's commitment to protecting information and managing high-level of information security. "We are expanding the use of cloud services in accordance with our SaaS business model and are making strong progress in transitioning to a pay-per-treatment (PPT) payment model. Managing patient information requires very high-level information security processes, which is why we started to pursue the ISO 27001 certification in Continue reading →

Modulight Announces Involvement in GlioLighT Project for Glioma Treatment

Modulight is pleased to announce its participation in the GlioLighT project, aimed at developing new treatment options for gliomas. This project has received substantial funding of approximately EUR 2.2 million over three years from the European Innovation Council’s Pathfinder program. The GlioLighT project partners include Johannes Gutenberg University Mainz, Aston University in Birmingham, the University of Barcelona, LMU Munich, and MODUS Research and Innovation Ltd. The budgetary allotment of the project for Modulight is about EUR 400,000 over the duration of the project. Gliomas, known Continue reading →Modulight is pleased to announce its participation in the GlioLighT project, aimed at developing new treatment options for gliomas. This project has received substantial funding of approximately EUR 2.2 million over three years from the European Innovation Council's Pathfinder program. The GlioLighT project partners include Johannes Gutenberg University Mainz, Aston University in Birmingham, the University of Barcelona, LMU Munich, and MODUS Research and Innovation Ltd. The budgetary allotment of the project for Modulight is about EUR 400,000 over the duration of the project. Gliomas, known Continue reading →

Modulight Forges Strategic Partnership with Laser 2000 UK for Market Expansion in the UK and Ireland

Modulight is pleased to announce a sales partnership with Laser 2000 UK Ltd, a renowned reseller of laser-based solutions in the UK and Ireland. The partnership marks a significant step in expanding Modulight’s presence in the UK and Irish markets, leveraging Laser 2000 UK’s established customer base, broad sales team, and technical expertise. Under this collaboration, Laser 2000 UK will integrate Modulight’s cutting-edge laser technologies into their diverse range of photonics solutions. This synergy is expected to enrich Laser 2000 UK’s system solutions offering, particularly Continue reading →Modulight is pleased to announce a sales partnership with Laser 2000 UK Ltd, a renowned reseller of laser-based solutions in the UK and Ireland. The partnership marks a significant step in expanding Modulight's presence in the UK and Irish markets, leveraging Laser 2000 UK's established customer base, broad sales team, and technical expertise. Under this collaboration, Laser 2000 UK will integrate Modulight's cutting-edge laser technologies into their diverse range of photonics solutions. This synergy is expected to enrich Laser 2000 UK's system solutions offering, particularly Continue reading →

Modulight launches ML6600 for Flow Cytometry and Quantum Computing

Next week at Photonics West 2024, Modulight will unveil significant new additions to the ML6600 laser solution platform. These new innovations include a specialized laser engine tailored for Flow Cytometry applications, and advanced DBR laser cores designed specifically for the Quantum Computing market. Our #LaserFamily are presenting 11 conference papers plus participating in a technical panel, across the Photonics West conferences BIOS, OPTO, LASE and QUANTUM WEST. You can see the list here. ML6600 for Flow Cytometry – Laser engine with active beam steering The newest product utilizing the ML6600 platform is a specialized laser engine for the Continue reading →Next week at Photonics West 2024, Modulight will unveil significant new additions to the ML6600 laser solution platform. These new innovations include a specialized laser engine tailored for Flow Cytometry applications, and advanced DBR laser cores designed specifically for the Quantum Computing market. Our #LaserFamily are presenting 11 conference papers plus participating in a technical panel, across the Photonics West conferences BIOS, OPTO, LASE and QUANTUM WEST. You can see the list here. ML6600 for Flow Cytometry – Laser engine with active beam steering The newest product utilizing the ML6600 platform is a specialized laser engine for the Continue reading →

Pioneering study confirms benefits of Modulight’s technology and photoimmunotherapy for ovarian cancer

A study published in Science Advances has for the first time scientifically demonstrated the potential of fluorescence-guided photoimmunotherapy enabled with Modulight’s laser platform and cloud technology. The study, a collaboration between the University of Maryland (UMD) and Modulight, confirms the benefits of targeted nanomedicine, Modulight’s medical laser system, and fluorescence-guided intervention in both achieving better treatment outcomes and predicting tumor response. “We have already published over a hundred scientific articles on our website from world-leading research groups that have used Modulight products in their studies. This Continue reading →A study published in Science Advances has for the first time scientifically demonstrated the potential of fluorescence-guided photoimmunotherapy enabled with Modulight's laser platform and cloud technology. The study, a collaboration between the University of Maryland (UMD) and Modulight, confirms the benefits of targeted nanomedicine, Modulight’s medical laser system, and fluorescence-guided intervention in both achieving better treatment outcomes and predicting tumor response. "We have already published over a hundred scientific articles on our website from world-leading research groups that have used Modulight products in their studies. This Continue reading →

World Congress organized by Modulight and the International Photodynamic Association brings world leading experts in Photodynamic therapy to Tampere

During this week, Tampere Hall will be filled with experts and scientists in photodynamic therapy as the international congress organized by Modulight gets underway. The biennial congress, the scientific content of which are carefully screened by the International Photodynamic Association (IPA), will give medical researchers, and doctors the opportunity to share their ideas, research results and new discoveries in the field of medicine and technology. The congress, which starts on Monday 10 July, will be opened by Anna-Kaisa Ikonen, Minister of Local Government of Finland, Continue reading →During this week, Tampere Hall will be filled with experts and scientists in photodynamic therapy as the international congress organized by Modulight gets underway. The biennial congress, the scientific content of which are carefully screened by the International Photodynamic Association (IPA), will give medical researchers, and doctors the opportunity to share their ideas, research results and new discoveries in the field of medicine and technology. The congress, which starts on Monday 10 July, will be opened by Anna-Kaisa Ikonen, Minister of Local Government of Finland, Continue reading →

Bausch + Lomb and Modulight Announce FDA Approval of ML6710i Photodynamic Laser for Use with Bausch + Lombs VISUDYNE (Verteporfin for Injection)

Bausch + Lomb and Modulight Announce FDA Approval of ML6710i Photodynamic Laser for Use with Bausch + Lomb’s VISUDYNE® (Verteporfin for Injection) VAUGHAN, Ontario and TAMPERE, Finland, Feb. 1, 2023 – Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, and Modulight Corporation (“Modulight”), a biomedical laser company, today announced that the U.S. Food and Drug Administration (FDA) has approved the ML6710i photodynamic laser for equivalent use with Bausch + Lomb’s VISUDYNE® (verteporfin for injection) photodynamic therapy (PDT) for the treatment Continue reading →Modulight Investor Contacts: Ulla Haapanen ulla.haapanen@modulight.com (408) 218-7960 Modulight Media Contacts: Zoe Ylöniemi zoe.yloniemi@modulight.com (408) 239-3488 Bausch + Lomb Investor Contacts: Arthur Shannon/Allison Ryan arthur.shannon@bausch.com allison.ryan@bausch.com (877) 354-3705 (toll free); (908) 927-0735 Bausch + Lomb Media Contacts: Lainie Keller/Kristy Marks lainie.keller@bausch.com kristy.marks@bausch.com (908) 927-1198; (908) 927-0683 Bausch + Lomb and Modulight Announce FDA Approval of ML6710i Photodynamic Laser for Use with Bausch + Lomb’s VISUDYNE® (Verteporfin for Injection) VAUGHAN, Ontario and TAMPERE, Finland, Feb. 1, 2023 – Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global Continue reading →

Modulight Geographic Expansion Continues in Europe with Laser 2000

PALO ALTO, CALIFORNIA & TAMPERE, FINLAND, 26TH JANUARY 2023 – Modulight Corp., a biomedical & semiconductor laser manufacturer, is expanding sales in Europe through a distribution partnership with Laser 2000, a pan European solutions provider for lasers and photonics since 1986. The exclusive partnership with Laser 2000 brings Modulight’s products available to customers in Germany, Austria, Switzerland, and France. Laser 2000 customers include several of the biggest technology companies in Europe. The expectation is that this collaboration with Laser 2000 will open significant sales opportunities Continue reading →PALO ALTO, CALIFORNIA & TAMPERE, FINLAND, 26TH JANUARY 2023 – Modulight Corp., a biomedical & semiconductor laser manufacturer, is expanding sales in Europe through a distribution partnership with Laser 2000, a pan European solutions provider for lasers and photonics since 1986. The exclusive partnership with Laser 2000 brings Modulight’s products available to customers in Germany, Austria, Switzerland, and France. Laser 2000 customers include several of the biggest technology companies in Europe. The expectation is that this collaboration with Laser 2000 will open significant sales opportunities Continue reading →

Modulight’s Kalle Palomäki Appointed as Vice Chair of the Enabling Technologies Technical Advisory Committee in QED-C

Modulight’s executive board member, Mr. Kalle Palomäki has been selected as the Vice Chair of the Enabling Technologies Technical Advisory Committee (TAC) in Quantum Economic Development Consortium (QED-C). QED-C is the key organization in the US that has the mission of accelerating the development of the US Quantum market. Celia Merzbacher, QED-C executive director, comments on Mr. Palomäki’s election for the Vice Chair: “Laser technology is especially fundamental in quantum systems, such as trapped ion and neutral atom based qubits, and quantum networking. Lasers truly Continue reading →Modulight’s executive board member, Mr. Kalle Palomäki has been selected as the Vice Chair of the Enabling Technologies Technical Advisory Committee (TAC) in Quantum Economic Development Consortium (QED-C). QED-C is the key organization in the US that has the mission of accelerating the development of the US Quantum market. Celia Merzbacher, QED-C executive director, comments on Mr. Palomäki’s election for the Vice Chair: “Laser technology is especially fundamental in quantum systems, such as trapped ion and neutral atom based qubits, and quantum networking. Lasers truly Continue reading →

Modulight joins the Quantum Economic Development Consortium (QED-C) to support quantum ecosystem initiatives

Modulight was invited as the first Finnish company to join the Quantum Economic Development Consortium (QED-C) to further support quantum ecosystem initiatives in the U.S. QED-C has support from multiple agencies and a diverse set of industry, academic, and other stakeholders. There are more than 200 members, including more than 150 corporations from across the quantum supply chain including quantum tech companies, component suppliers and manufacturers, hardware and software system developers, service providers and end-users. As a QED-C participant, Modulight is working to identify gaps Continue reading →Modulight was invited as the first Finnish company to join the Quantum Economic Development Consortium (QED-C) to further support quantum ecosystem initiatives in the U.S. QED-C has support from multiple agencies and a diverse set of industry, academic, and other stakeholders. There are more than 200 members, including more than 150 corporations from across the quantum supply chain including quantum tech companies, component suppliers and manufacturers, hardware and software system developers, service providers and end-users. As a QED-C participant, Modulight is working to identify gaps Continue reading →